Plunkett Research Online: ConjuChem Biotechnologies Inc

CONJUCHEM BIOTECHNOLOGIES INC (CCHXF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ConjuChem Biotechnologies Inc is a Canada based biotechnology company. It is primarily engaged in the business of creating novel, next-generation medicines using long-acting therapeutic peptides. The company’s compounds are bio-conjugation platforms called Drug Affinity Complex (DAC) and Preformed C.....



ConjuChem Biotechnologies Inc
Ticker: CCHXF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 514 844-5558
Fax: 1 514 844-1119
Address: 225 President-Kennedy Avenue
Suite 3950
Montreal, QC H2X 3Y8 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Mark PerrinCEO/Director/President
Steve PerroneDirector
See More
ConjuChem Biotechnologies Inc is a Canada based biotechnology company. It is primarily engaged in the business of creating novel, next-generation medicines using long-acting therapeutic peptides. The company’s compounds are bio-conjugation platforms called Drug Affinity Complex (DAC) and Preformed C.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: